Web Results

STEED v. BAYER HEALTHCARE PHARMACEUTICALS, INC. et al ...

www.pacermonitor.com/public/case/19931588/STEED_v_BAYER_HEALTHCARE_PHARMACEUTICALS,_INC_et_al

6 days ago ... STEED v. BAYER HEALTHCARE PHARMACEUTICALS, INC. et al (2:16-cv- 08786), New Jersey District Court, Filed: 11/28/2016 ...

JACKSON v. BAYER HEALTHCARE PHARMACEUTICALS, INC. et al

www.pacermonitor.com/public/case/20014619/JACKSON_v_BAYER_HEALTHCARE_PHARMACEUTICALS,_INC_et_al

5 days ago ... JACKSON v. BAYER HEALTHCARE PHARMACEUTICALS, INC. et al (2:16-cv- 08832), New Jersey District Court, Filed: 11/29/2016 ...

The Myocardial Extracellular Volume Fraction from T1 ... - NCBI

www.ncbi.nlm.nih.gov/pmc/articles/PMC3683385/

May 1, 2013 ... 0.30 ± 0.02, juvenile vs. aged mice, p< 0.001). ... The protocol was approved by the Partners Healthcare System Human Subjects Review Committee ... dose of gadolinium DTPA (Magnevist, Bayer HealthCare Pharmaceuticals Inc, Wayne, New Jersey). ..... Jerosch-Herold M, Sheridan DC, Kushner JD, et al.

Genetic Interactions Found Between Calcium Channel Genes ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC4045094/

Sep 12, 2013 ... 2009; 2010), and tau phosphorylation genes (Mateo et al. ... private pharmaceutical companies and non-profit organizations, as a $60 million, ... interaction analysis using the publicly available InterSNP program (Herold et al. ..... AstraZeneca; Bayer HealthCare; BioClinica, Inc; Biogen Idec Inc; Bristol- Myers .....

B7-H1 shapes T-cell–mediated brain endothelial cell dysfunction ...

www.pnas.org/content/early/2016/09/21/1601350113.abstract

Sep 26, 2016 ... ... from Genzyme (2014), Novartis Pharma GmbH (2011), and Bayer Health Care (2014). ... Tobias V Lanz et al., Proc Natl Acad Sci U S A, 2013.

Mark T. Jansen: Litigation & Trial/Intellectual Property Litigation ...

www.crowell.com/Professionals/Mark-Jansen

Watson Pharmaceuticals, Inc., et al., District of Nevada and Federal Circuit Court ... Reported appellate decision: Bayer Healthcare Pharm., Inc. v. .... Contacts: Mark T. Jansen, Anne Elise Herold Li, Mary Anne Schofield, Ph.D., Pilar Stillwater .

Alefacept provides sustained clinical and immunological effects in ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC4623571/

Jul 20, 2015 ... Bayer HealthCare LLC, Diabetes Care provided blood glucose monitoring supplies through an investigator-sponsored ... Herold KC, et al.

Myocardial Extracellular Volume Fraction From T1 ... - ScienceDirect

www.sciencedirect.com/science/article/pii/S1936878X13002702

May 1, 2013 ... 0.30 ± 0.02, juvenile vs. aged mice, p < 0.001). ... The protocol was approved by the Partners Healthcare System Human Subjects Review Committee ... pentaacetic acid (Magnevist, Bayer HealthCare Pharmaceuticals Inc., Wayne, New Jersey). ..... 13; M. Jerosch-Herold, D.C. Sheridan, J.D. Kushner, et al.

Myocardial Extracellular Volume Fraction From T1 Measurements in ...

imaging.onlinejacc.org/pdfaccess.ashx?ResourceID=5760322&PDFSource=13

HealthCare Pharmaceuticals Inc., Wayne, New. Jersey). ..... compared to “normal ” myocardium. Lee et al. (26) measured myocardial T1 values at 3-T in normal.

More Info

COAPMAN v. BAYER HEALTHCARE PHARMACEUTICALS, INC. et al

www.pacermonitor.com

5 days ago ... COAPMAN v. BAYER HEALTHCARE PHARMACEUTICALS, INC. et al (2:16-cv- 08834), New Jersey District Court, Filed: 11/29/2016 ...

STORY et al v. BAYER HEALTHCARE PHARMACEUTICALS, INC ...

www.pacermonitor.com

Nov 28, 2016 ... STORY et al v. BAYER HEALTHCARE PHARMACEUTICALS, INC. et al (2:16-cv- 06200), Pennsylvania Eastern District Court, Filed: ...

T1 Measurements for Detection of Expansion of the Myocardial ...

www.ncbi.nlm.nih.gov

Aug 19, 2014 ... ... MD,<sup>d</sup> Michael Jerosch-Herold, PhD,<sup>e</sup> Raymond Y. Kwong, MD MPH,<sup>c</sup> and Atul Malhotra, .... DTPA (Magnevist, Bayer HealthCare Pharmaceuticals Inc, Wayne, New Jersey). ..... Farzaneh-Far A, Ariyarajah V, Shenoy C, et al.